. Multiple in-frame vesicles were transplanted between the large-eyed Ambystoma tigrinum and the small-eyed Ambystoma puncstop codons are present prior to the initiation codon and following the termination codon. A consensus site tatum, the tigrinum eye became disproportionately large for its punctatum host, while the grafted punctatum eyefor polyadenylation is also present at position 1563. Three features of the predicted amino acid sequence of bud preserved its small size in spite of the fact that it was nourished by a much larger and rapidly growing the cDNA identify it as a member of the Six/so family and a likely Xenopus ortholog of Optx2: the Six domain, host (Stone, 1930; reviewed in Twitty, 1955).
Expression Patterns of XOptx2 in the Developing
Xenopus embryos. Neither ␤-gal nor GFP affects eye development. However, when XOptx2 RNA was injected Embryo and during Eye Formation XOptx2 mRNA expression is first detected in stage 14 into embryos, we observed an obvious enlargement of the eye on the injected side ( Figure 3 ). This phenotype embryos (not shown). At stage 15, XOptx2 is detected as a single band of expression at the most anterior edge was detected in embryos injected with 5 pg of XOptx2 RNA and was maximal in embryos injected with between of the developing neural plate (Figure 2A) . At approximately stage 17, expression extends laterally ( Figure  7 .5 and 12.5 pg. On average, 10 pg of XOptx2 increased eye volume by an impressive 70%, although it was not 2B). By neural groove stage (stage 18), this single band of expression separates into two distinct regions consisuncommon to see eyes twice as large as normal. The minimum dosage required to observe an increase in eye tent with the location of the eye fields ( Figure 2C ). As the protrusion of the eyes begins to become distinct size varied from clutch to clutch of embryos, but the effect was always dose dependent-inducing larger (stage 20 to 22), XOptx2 expression appears restricted to the eyes ( Figures 2D and 2E) . At stage 25, XOptx2 is eyes at higher doses. Because we used the uninjected side of the embryo as a control, we were interested to also detected in the pineal gland primordia and the ventral forebrain ( Figure 2F ). Expression continues to be know whether the relative increase in the size of the eye on the XOptx2-overexpressing side was caused by the detected in the eyes, the maturing pineal gland (not shown), and the ventral forebrain of tailbud embryos unequal separation of the eye fields. Therefore, we compared the average size of the control eye of XOptx2-( Figure 2G ).
In sections of Xenopus embryos after neural tube forinjected embryos to that of age-matched controls (uninjected or tracer injected) and found they were identical mation, XOptx2 expression is detected in the protruding primary optic vesicle ( Figure 2H of the eye on the injected side was often similar to a downward-turned horseshoe (luck running out) rather to diminish in the region immediately adjacent to the developing pigmented epithelium that will form the outer than the typical doughnut-shaped pigmentation of the mature eye ( Figures 3A and 3B ). The optic fissure did nuclear (photoreceptor) layer. To correlate the generation of photoreceptors with the loss of XOptx2 expresnot close properly, which did not allow for the proper formation of the pigmentation on the ventral side of the sion, we costained Xenopus retina to detect XOptx2 RNA and rhodopsin. By stage 41, rhodopsin is strongly eye (see Figure 4A ). Although the lens was enlarged on the injected side expressed in the photoreceptor layer ( Figure 2M ), where XOptx2 expression is not detected ( Figure 2L ). Con-(by 22%, n ϭ 5), its diameter remained proportional to eye diameter (lens/eye diameter ratio is 0.27 in XOptx2-trasting patterns in XOptx2 and rhodopsin expression are also evident in the ventral retina, where cellular difoverexpressing eyes and 0.28 in controls). This is consistent with work involving cross-species transplantation of ferentiation is delayed relative to the dorsal retina (Figures 2L and 2M) . In this region, and in the continuously optic cups in salamander embryos, which demonstrated that lens size is far less autonomous than eye size (Rotproliferating ciliary marginal zone (CMZ), XOptx2 expression is maintained. mann, 1939, 1940 5F , and 5J). ET is In Drosophila, sine oculis physically interacts with eyes absent through the Six domain, and together they can expressed in both the eye field and the cement gland ( Figure 5F ). XOptx2 differentially regulates ET expresinduce ectopic compound eye formation (Pignoni et al., 1997). We wondered if similar synergistic effects might sion in these two domains-simultaneously increasing ET expression in the eye field and decreasing it in the be observed in vertebrate eye development. We therefore overexpressed XOptx2 and XPax6 in Xenopus emcement gland ( Figure 5F ). We do not know the significance of this downregulation, as the cement gland apbryos by RNA injection. XPax6 alone had no effect on eye or brain size at concentrations as high as 60 pg per peared to form normally in older embryos. embryo (not shown). However, at doses as low as 2.5 pg, XPax6 potentiates the effect of XOptx2 on eye enlargement ( Figure 6A ). XPax6 also potentiates the effect of XOptx2 at higher concentrations where the enlarged brain phenotype predominates. Greater than 15 pg of XOptx2 is required to induce brain enlargement. However, when equal quantities of XPax6 and XOptx2 are coinjected, as little as 10 pg of XOptx2 induces brain enlargement ( Figure 6B ).
XOptx2 Acts Like a Transcriptional Repressor
In Xenopus, a species in which gene knockouts are not yet an option, functional characterization of transcription factors has been accomplished using activator and repressor domain fusions (Ryan et al., 1996) . We therefore fused the homeodomain of XOptx2 to the Engrailed (EnR) repressor domain, creating XOptx2HD-EnR. Because the homeodomain of XOptx2 is so similar to the homeodomain of Six3, we also fused the entire coding sequence of XOptx2 to the Engrailed repressor domain, creating XOptx2-EnR. When overexpressed by injection of RNA into a single blastomere, XOptx2HD-EnR caused a similar phenotype to XOptx2 alone, that is, an enlargement of the eye at low dose (n ϭ 12 of 12; Figure 3K ) and brain enlargement at high doses (n ϭ 18 of 18; not shown). Similar results were obtained with XOptx2-EnR. To test specificity directly, we injected the Engrailed repressor RNA alone. This had no effect on embryos, and eyes expressing EnR appeared normal. We used in situ hybridization to determine the effect of XOptx2HD-EnR on Rx1 expression. XOptx2HD-EnR increased the domain of expression of Rx1 in a manner similar to that observed in XOptx2-overexpressing embryos ( Figures  5G and 5I) .
Interference with XOptx2 Function
Because XOptx2 functions like a repressor, we reasoned that conversion of its repressor function into an activator function might result in an antimorphic phenotype similar to a knockout. Therefore, we fused the activation domain of VP16 (Mariani and Harland, 1998) to the homeodomain of XOptx2, creating XOptx2HD-VP16. Overexpression of as little as 25 pg of XOptx2HD-VP16 in Xenopus embryos dramatically reduced and sometimes eliminated eye formation on the injected side of the animal (Figures 3I, 3J, and 3L) . The severity of the phenotype increased in a dose-dependent manner. In con- To increase the probability that we were examining true clones, we minimized the amount of DNA lipofected so that most retinas contained either no transfected cells or single "clones." Second, when more than one cluster was detected in transfected retinas, they were scored only if the clusters were well separated.
Interestingly, XOptx2 had no effect on the relative proportion of cell types generated from transfected cells in these clones ( Figure 7A ). This result implies that XOptx2 does not influence retinal cell fate per se. However, XOptx2 nearly doubled the number of GFP-positive cells in retinal clones (Figures 7B-7D) . The average clone size in XOptx2-transfected retinas was 16.1 cells per retinal section, while the cell number observed in control-expressing clones was 10.4. These results indicate that XOptx2 induces proliferation. A, B, D While XOptx2 induces an eye field expansion in 75% of the untreated injected embryos, HU treatment inhibited the XOptx2-induced increase in eye field size in two independent experiments ( Figure 7D ). In these cases, only 17% and 11% of XOptx2-injected embryos showed slightly enlarged eye fields when cultured in HU, and even more showed slightly reduced eye fields (Figure 7D) .
, G, and H), Pax6 (C), ET (F), and ␤-tubulin (E) expressions. ␤-gal had no effect on Rx1 expression (A). The domain of Rx1 expression was expanded in XOptx2-injected embryos (B and D). XOptx2 induced the expression of Rx1 across the midline (arrow) into the optic stalk/ventral forebrain region (D). XOptx2 enlarged the boundary of Pax6 expression (C, arrows). XOptx2 simultaneously induces ET expression in the eye field (F, arrows) and inhibits it in the developing cement gland (F, arrowhead). XOptx2 delays the expression of ␤-tubulin (E, stage 22). The domain of Rx1 expression was expanded in XOptx2HD-EnR-injected embryos (G) and decreased in XOptx2HD-VP16-injected embryos (H)
Another possible explanation for the increase in eye size is that XOptx2 inhibits apoptosis. We therefore labeled embryos injected with XOptx2 mRNA in one blastomere and examined cell death by TUNEL (TdT-mediated dUTP-biotin nick end labeling) assay in the overexpressing and normal retina. Instead of finding fewer apoptotic figures in XOptx2-overexpressing eyes, we found nearly twice as many (injected eye, 298, vs. control eye, 157; n ϭ 6). These data obviously do not support the hypothesis that XOptx2 is antiapoptotic and rather suggest that we may be underestimating the hyperproliferation caused by its overexpression.
We observed a delay in the expression of neural ␤-tubulin in the brains of XOptx2-injected embryos (Figures 5E and 5J) . Although expression of ␤-tubulin was delayed in early-stage embryos, late-stage embryos showed a significant increase in ␤-tubulin expression, as one would expect with the enlarged brain size (Figures 4E and 5J) . The delay in the expression of such a inhibitors, and rb, are expressed in retinoblasts, so it will be useful to investigate the relationship between XOptx2 and these genes in future studies. Our cyclin XOptx2 is normally expressed in the eye; (4) overexpres-A2 and CDK2 experiments imply that different tissues sion of XOptx2 increases proliferation of neural cells; respond differently to overexpression of selected comand (5) Pax6 and XOptx2 act synergistically on eye formation.
ponents of the cell cycle machinery. here, although they in no way suggest that XOptx2 and
